CStone Pharmaceuticals (STU:PH4) Change In Receivables : €11.77 Mil (TTM As of Jun. 2023)

View and export this data going back to 2019. Start your Free Trial

What is CStone Pharmaceuticals Change In Receivables?

CStone Pharmaceuticals's change in receivables for the quarter that ended in Jun. 2023 was €0.00 Mil. It means CStone Pharmaceuticals's Accounts Receivable stayed the same from Dec. 2022 to Jun. 2023 .

CStone Pharmaceuticals's change in receivables for the fiscal year that ended in Dec. 2023 was €-12.24 Mil. It means CStone Pharmaceuticals's Accounts Receivable increased by €12.24 Mil from Dec. 2022 to Dec. 2023 .

CStone Pharmaceuticals's Accounts Receivable for the quarter that ended in Jun. 2023 was €0.00 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. CStone Pharmaceuticals's Days Sales Outstanding for the six months ended in Jun. 2023 was 0.00.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. CStone Pharmaceuticals's liquidation value for the six months ended in Jun. 2023 was €0.00 Mil.

CStone Pharmaceuticals Change In Receivables Historical Data

The historical data trend for CStone Pharmaceuticals's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CStone Pharmaceuticals Change In Receivables Chart

CStone Pharmaceuticals Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

-16.34

5.48

-12.24

CStone Pharmaceuticals Semi-Annual Data
	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Change In Receivables	Get a 7-Day Free Trial									-9.33	-6.56	11.77	-	-

CStone Pharmaceuticals Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €11.77 Mil.

CStone Pharmaceuticals (STU:PH4) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

CStone Pharmaceuticals's Days Sales Outstanding for the quarter that ended in Jun. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0	/	33.7	*	91
=	0.00

2. In Ben Graham's calculation of liquidation value, CStone Pharmaceuticals's accounts receivable are only considered to be worth 75% of book value:

CStone Pharmaceuticals's liquidation value for the quarter that ended in Jun. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	0	-	0	+	0.75 * 0	+	0.5 * 0
=	0.00

CStone Pharmaceuticals Change In Receivables Related Terms

Thank you for viewing the detailed overview of CStone Pharmaceuticals's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

CStone Pharmaceuticals (STU:PH4) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CStone Pharmaceuticals (STU:PH4) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

CSPHF:USA 02616:Hong Kong

Address

218 Xinghu Street, C1 Building, North Block, Suzhou Industrial Park, Shanghai, CHN, 215123

Website

https://www.cstonepharma.com

CStone Pharmaceuticals is engaged in the development and commercialization of innovative tumor immunotherapy and molecular-targeted drugs. It has been operating in one reportable segment, the research and development of complex biopharmaceutical products.

CStone Pharmaceuticals (STU:PH4) Headlines

No Headlines